All Posts By

Smartkarma Daily Briefs

Daily Brief Industrials: Doosan Robotics , Medi Assist Healthcare Services, Joby Aviation , Timee Inc, NEXTracker and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Doosan Group: Index Implications of the Corporate Restructuring
  • Medi Assist US$180m Lock-Up Expiry – Multibagger Gains Are Ripe for the Taking
  • Joby Aviation (JOBY) – Tuesday, Apr 16, 2024
  • Timee IPO: Forecasts and Valuation
  • Nextracker Inc.: A Competitive Advantage Through Global Expansion and Market Diversification!


Doosan Group: Index Implications of the Corporate Restructuring

By Brian Freitas


Medi Assist US$180m Lock-Up Expiry – Multibagger Gains Are Ripe for the Taking

By Clarence Chu

  • Medi Assist Healthcare Services (0886371D IN) was listed on 23rd Jan 2024 after raising US$140m. The IPO had been 100% secondary, with the promoters and pre-IPO investors trimming their stakes.
  • Medi Assist Healthcare Services (Medi Assist) provides third party administration services to insurance companies via its subsidiaries.
  • Coming up for six-month lockup expiry are the firm’s pre-IPO shareholders and a portion of the promoters’ stakes.

Joby Aviation (JOBY) – Tuesday, Apr 16, 2024

By Value Investors Club

  • Strong team, innovative product, and potential market demand in auto tech space support highly speculative projections for investment in Joby Aerospace
  • Despite concerns about aggressive projections, company’s current valuation offers attractive entry point for investors seeking substantial upside with decent margin of safety
  • Joby’s eVTOL aircraft development and plans for air taxi service differentiate it from other failed SPAC ventures, positioning it as top-tier hard tech startup with potential for success

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Timee IPO: Forecasts and Valuation

By Shifara Samsudeen, ACMA, CGMA

  • Timee has set an indicative IPO price range of ¥1,350-1,450 per share and will raise US$280m (at the midpoint) where existing shareholders will sell down part of their ownership.
  • We expect Timee’s earnings to grow as the company is still in its early stages and with further growth in scale, we expect Timee’s margins to continue to expand further.
  • Our analysis shows that Timee Inc (215A JP) IPO is valued attractively as the company has better-than-peer margin profile which suggests that there is further upside to implied valuation multiples.

Nextracker Inc.: A Competitive Advantage Through Global Expansion and Market Diversification!

By Baptista Research

  • Nextracker’s Fourth Quarter and Full Fiscal Year 2024 conference detailed a period of significant achievement and robust performance, balanced by a practical outlook on the evolving challenges and opportunities in the solar industry.
  • The company reported a strong year with highlights including a 40% annual increase in Q4 revenue to $737 million and a doubling of adjusted EBITDA to $160 million for the same period.
  • This capped a fiscal year where revenue soared over 30% to hit $2.5 billion with adjusted EDBITA more than doubling to $521 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Niva Bupa Health Insurance, Record PLC, Zip , Bitcoin Pro, FP Partner and more

By | Daily Briefs, Financials

In today’s briefing:

  • Niva Bupa Health Insurance Pre-IPO Tearsheet
  • Record – Transitional year ahead
  • ZIP Placement – Worth a Small Punt, at Best
  • The Bulls Strike Back
  • FP Partner (7388 JP): 1H FY11/24 flash update


Niva Bupa Health Insurance Pre-IPO Tearsheet

By Clarence Chu

  • Niva Bupa Health Insurance (1226871D IN) is looking to raise US$360m in its upcoming India IPO. The bookrunners on the deal are MS, Kotak, Axis, ICICI, HDFC, and Motilal Oswal.
  • Niva Bupa Health Insurance (Niva Bupa) is a health insurance firm. Its portfolio consists of health (including retail and group), personal accident, and travel insurance.
  • As per Redseer, the firm was one of India’s largest and fastest growing standalone health insurers (SAHI) based on overall health gross direct premium income (GDPI) in FY24. 

Record – Transitional year ahead

By Edison Investment Research

Record reported FY24 PBT of £12.9m, down 12% y-o-y and in line with our estimate of £12.8m. Underlying PBT was £14.8m, up 2% y-o-y on record assets under management (AUM), which grew 16.5% to $102.2bn. The final ordinary dividend surprised positively at 2.45p, above our 2.36p forecast, and a special dividend of 0.6p was declared. As new CEO Dr Jan Witte continues to refocus the strategy over the next six months, the company is guiding to relatively flat management fees. We have cut our FY25 PBT estimate to £12.1m (previously £14.8m) on a weaker fee revenue projection. We also initiate FY26 PBT and diluted EPS estimates at £14.0m and 5.43p, respectively. The cash-generative business model enables the group to continue to pay an attractive ordinary dividend.


ZIP Placement – Worth a Small Punt, at Best

By Sumeet Singh

  • Zip (ZIP AU) plans to raise around US$145m in order to repay its outstanding debt.
  • The company has undertaken a number of deals in the past and has a mixed track record.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

The Bulls Strike Back

By Delphi Digital

  • BTC reclaims multi-month range lows, hinting at potential bullish momentum despite recent sell pressure.
  • Spot ETF inflows surge, showing resilience even as BTC faced significant market cap erosion.
  • ETH spot ETF launch set for July 23, could spark renewed market interest and opportunities.

FP Partner (7388 JP): 1H FY11/24 flash update

By Shared Research

  • Revenue was JPY17.1bn (+17.6% YoY), with life insurance commission revenue at JPY16.4bn (+18.2% YoY).
  • Operating profit was JPY2.7bn (-0.2% YoY), with an OPM decrease of 2.8pp YoY to 15.7%.
  • Acquisition of 333,000 treasury shares for JPY1.0bn, with cancellation scheduled for August 30, 2024.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Honda Motor, Samson Holding, Hyundai Motor India , Kalyan Jewellers, Limoneira Co, Grocery Outlet Holding Corp, Corn Active Contract, Bloks Group, Toll Brothers and more

By | Consumer, Daily Briefs

In today’s briefing:

  • The Honda (7267) Offering – Much Easier Than It Looks
  • Honda (7267 JP): The Current Playbook
  • Samson Holding (531 HK): Chairman’s Scheme Privatisation at HK$0.48
  • Hyundai Motor India IPO: The Bear Case
  • Kalyan Jewellers (KALYANKJ IN): Riding the Big Fat Indian Wedding Boom
  • Limoneira Co (LMNR) – Tuesday, Apr 16, 2024
  • Grocery Outlet Holding Corp.: Leveraging Digital Platforms to Augment Customer Engagement! – Major Drivers
  • Latest WASDE Paints Agri Bearishness; Wheat Harvest Dominates While Corn & Beans Find Thin Support
  • Pre-IPO Bloks Group – High Growth May Not Be Sustainable
  • Company Update – TOLL BROTHERS


The Honda (7267) Offering – Much Easier Than It Looks

By Travis Lundy

  • At the beginning of this month, we got a scoop from Reuters about a US$3bn selldown of Honda Motor (7267 JP) by P&C insurers and others. 
  • We knew this was coming at some point. The FSA had pushed the insurers to unwind cross-holdings, and it is otherwise of the zeitgeist. 
  • It came out as heavily retail-oriented, and the supply/demand details are otherwise interesting. To boot, there is an EPS boost to come.

Honda (7267 JP): The Current Playbook

By Arun George

  • Since the US$3.3 billion secondary placement announcement, Honda Motor (7267 JP)’s shares are down 5% from the undisturbed price of JPY1,791 per share (4 July).
  • Looking at recent large Japanese placements is instructive to understand the potential trading pattern. So far, Honda’s shares have followed the pattern of previous large placements.
  • The offering will likely be priced on 17 July. Investors who have participated in previous large Japanese placements tend to secure positive returns.

Samson Holding (531 HK): Chairman’s Scheme Privatisation at HK$0.48

By Arun George

  • Samson Holding (531 HK) disclosed a Cayman scheme privatisation offer from Mr Samuel Kuo (Chairman) at HK$0.48 per share, a 77.8% and 50.0% premium to undisturbed and last close price, respectively. 
  • The key condition will be approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). The offer price is final.
  • The attractive takeover premium, lack of shareholders holding a blocking stake, and low AGM minority participation rate point to a done deal. However, this is a small cap illiquid stock.

Hyundai Motor India IPO: The Bear Case

By Arun George


Kalyan Jewellers (KALYANKJ IN): Riding the Big Fat Indian Wedding Boom

By Devi Subhakesan

  • Kalyan Jewellers (KALYANKJ IN) , a leading jeweller with a pan-India presence, is expected to deliver strong sales growth, and improving returns with its asset-light expansion plans.
  • Indian weddings have transformed from simple rituals to elaborate celebrations requiring heavy spending on jewellery and specialty apparel, reflecting rising affluence and media influence.
  • Wedding related jewellery demand constitutes 60% of India’s total gold jewellery demand and remains resilient regardless of price changes.

Limoneira Co (LMNR) – Tuesday, Apr 16, 2024

By Value Investors Club

  • Limoneira is an agribusiness with underutilized land and water assets, resulting in poor returns for shareholders
  • Peter Nolan, a successful asset manager from Leonard Green, has joined the board along with Global Alpha, indicating a potential turnaround in capital allocation and strategy
  • Nolan’s leadership is expected to unlock the potential of Limoneira’s assets, leading to significant returns for shareholders

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Grocery Outlet Holding Corp.: Leveraging Digital Platforms to Augment Customer Engagement! – Major Drivers

By Baptista Research

  • Grocery Outlet reported fiscal Q1 2024 results that reflected mixed performance, illustrating both operational challenges and promising growth prospects.
  • During the quarter, the company recorded a 7.4% increase in sales, achieving $1.04 billion, spurred on by a 3.9% rise in comparable store sales and reinforced by robust transaction count growth of 7%.
  • This reflects Grocery Outlet’s continued customer appeal and effective store expansion strategy, having opened six new stores during this period.

Latest WASDE Paints Agri Bearishness; Wheat Harvest Dominates While Corn & Beans Find Thin Support

By Srinidhi Raghavendra

  • Strong American harvest driving downward pressure on Wheat, likely to offset reductions in EU and Russia.
  • Corn saw modest recovery, driven by muted ending stocks, below trade estimate, but the harvest is going to be the third largest ever.
  • US soybean production remains muted, in line with the Acreage report, and led to moderate recovery in early trading on Friday, but bearish sentiment persists.

Pre-IPO Bloks Group – High Growth May Not Be Sustainable

By Xinyao (Criss) Wang

  • The key for high growth in 2023/24Q1 lies in its assembly character toys with renowned IPs,which may not be sustainable or even collapse if Bloks fails to renew license agreements.
  • The advantages of Bloks in development prospects, self-developed IPs, brand stickiness are not obvious. The latest valuation reached RMB7.2 billion, but the founder has already cashed out before IPO. 
  • Hong Kong stock market has been “lukewarm” to toy companies. Except Pop Mart, valuation/share price of peers are quite weak.How to gain investor/market’s recognition for Bloks is a question mark.

Company Update – TOLL BROTHERS

By VRS (Valuation & Research Specialists)

  • Our estimations for FY 2024 annual revenue range at around $10,827 million and for 2025 at around $12,090 million.
  • The company’s annual revenue reached $9,995 million in 2023 compared to $10,276 million in 2022, posting a decrease of 2.73%.
  • Toll Brothers gross profit for FY 2023 was $2,634 million increased by 5.95% com- pared to $2,486 million for the corresponding period of 2022.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: China Traditional Chinese Medicine, TIS, Doosan Robotics , Honda Motor, Samson Holding, Gigabyte Technology, PC Partner and more

By | Daily Briefs, Most Read

In today’s briefing:

  • China TCM (570.HK) Update – Behind The Share Price Plunge and Prospects for Privatization Progress
  • China Traditional Chinese Medicine (570 HK): Update Provides Fodder for Bulls and Bears
  • Japan – Yet Another Big Round of Passive Selling Expected in August
  • Doosan Group: Index Implications of the Corporate Restructuring
  • The Honda (7267) Offering – Much Easier Than It Looks
  • Honda (7267 JP): The Current Playbook
  • Samson Holding (531 HK): Chairman’s Scheme Privatisation at HK$0.48
  • Honda Motor Placement – Past Large Deals Analysis – Could Do with a Bit More Correction
  • Gigabyte GDRs Early Look – While Core Segment Has Slowed, Had Benefited from the AI Server Wave
  • Further “SGX Listing & HKEx Withdrawal” Musings


China TCM (570.HK) Update – Behind The Share Price Plunge and Prospects for Privatization Progress

By Xinyao (Criss) Wang

  • The slow progress of privatization is related to recent high-level changes in CNPGC. Decisions on SOE deals with “strategic purpose” require careful considerations, not based on “one leader’s personal preferences”.
  • Based on public information, we cannot find convincing reason to prove that CNPGC has changed its mind.There’re rumors that China TCM’s privatization is still considered important project on the agenda.
  • China TCM’s has strong fundamentals to support valuation. If there is no announcement, the privatization process is expected to proceed as usual, and we continue to wait for the voting.  

China Traditional Chinese Medicine (570 HK): Update Provides Fodder for Bulls and Bears

By Arun George

  • China Traditional Chinese Medicine (570 HK)’s monthly update provides ammunition to both the bulls and bears. Since falling on no news on 26 June, the spread has widened to 31.8%. 
  • The bull view is that while the timelines are delayed, the privatisation remains on track as the update shows ongoing progress in satisfying the pre-condition. 
  • The bear view is that progress remains glacial, as the consortium wants to withdraw from a binding offer by failing to satisfy the pre-condition before the long stop date.

Japan – Yet Another Big Round of Passive Selling Expected in August

By Brian Freitas

  • There are a bunch of stocks that have underperformed the Nikkei 225 (NKY INDEX) and their peers and could be deleted from global passive portfolios in August.
  • The deletion from passive portfolios will lead to a liquidity event at the end of August where passive trackers will need to sell multiple days of ADV.
  • Shorts have been built up on all the stocks over the last few months and the extent of the positioning varies across stocks.

Doosan Group: Index Implications of the Corporate Restructuring

By Brian Freitas


The Honda (7267) Offering – Much Easier Than It Looks

By Travis Lundy

  • At the beginning of this month, we got a scoop from Reuters about a US$3bn selldown of Honda Motor (7267 JP) by P&C insurers and others. 
  • We knew this was coming at some point. The FSA had pushed the insurers to unwind cross-holdings, and it is otherwise of the zeitgeist. 
  • It came out as heavily retail-oriented, and the supply/demand details are otherwise interesting. To boot, there is an EPS boost to come.

Honda (7267 JP): The Current Playbook

By Arun George

  • Since the US$3.3 billion secondary placement announcement, Honda Motor (7267 JP)’s shares are down 5% from the undisturbed price of JPY1,791 per share (4 July).
  • Looking at recent large Japanese placements is instructive to understand the potential trading pattern. So far, Honda’s shares have followed the pattern of previous large placements.
  • The offering will likely be priced on 17 July. Investors who have participated in previous large Japanese placements tend to secure positive returns.

Samson Holding (531 HK): Chairman’s Scheme Privatisation at HK$0.48

By Arun George

  • Samson Holding (531 HK) disclosed a Cayman scheme privatisation offer from Mr Samuel Kuo (Chairman) at HK$0.48 per share, a 77.8% and 50.0% premium to undisturbed and last close price, respectively. 
  • The key condition will be approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). The offer price is final.
  • The attractive takeover premium, lack of shareholders holding a blocking stake, and low AGM minority participation rate point to a done deal. However, this is a small cap illiquid stock.

Honda Motor Placement – Past Large Deals Analysis – Could Do with a Bit More Correction

By Sumeet Singh

  • A group of shareholders aims to raise up to US$3.2bn via selling around 5% of Honda Motor (7267 JP).
  • The possibility of such a selldown was flagged by Reuters prior to the deal launch.
  • In our earlier note, we spoke about the deal dynamics. In this note, we talk about the updates since then.

Gigabyte GDRs Early Look – While Core Segment Has Slowed, Had Benefited from the AI Server Wave

By Clarence Chu

  • Gigabyte Technology (2376 TT) is looking to raise up to US$350m in its upcoming GDR offering. The firm is also looking to raise another US$300m via convertible bonds.
  • In late Jun 2024, Gigabyte announced that it had received its shareholder’s approval to issue between 32-38m common shares via a GDR offering. 
  • Similar to previous GDR listings, the deal is a long drawn out process with the firm required to jump through a number of board/shareholder/regulatory approval loops.

Further “SGX Listing & HKEx Withdrawal” Musings

By David Blennerhassett

  • Back on the 18th June, personal computer parts and accessories play PC Partner (1263 HK)  announced a SGX listing was under consideration; and a possible withdrawal of the HKEx listing.
  • This development was discussed in PC Partner (1263 HK) Muses SGX Listing & HKEx Withdrawal.  PC Partner subsequently announced a privatisation would not accompany any proposed withdrawal (should it happens).
  • My recent discussions with SFC confirms this is possible. And there was a recent precedent. But there may be caveats.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief ESG: Determine Whether Shareholder Return Is a Temporary Measure or a Shift to Value-Creating Management and more

By | Daily Briefs, ESG

In today’s briefing:

  • Determine Whether Shareholder Return Is a Temporary Measure or a Shift to Value-Creating Management


Determine Whether Shareholder Return Is a Temporary Measure or a Shift to Value-Creating Management

By Aki Matsumoto

  • The dissolution of cross-shareholdings and changing environment in which foreign ownership has risen to 30% have changed the view of activist investors. TSE is one such example of big change.
  • It’s convenient that activist investors can use “TSE requested” language that is both easily understood and undeniable by the company when communicating with the portfolio company to improve its issues.
  • We must determine whether this is a temporary return to shareholders until the activist investors are removed from the shareholder list, or a shift to value-creating management.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): NSE Is Making Future & Options Trading Harder!!! and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • NSE Is Making Future & Options Trading Harder!!!
  • Ohayo Japan | Trump Trade
  • Biopharma Week in Review – July 15, 2024
  • Furniture/Furnishings Weekly – July 15, 2024
  • The Highlights – Cannabis News for the Week Ending July 12, 2024


NSE Is Making Future & Options Trading Harder!!!

By Nimish Maheshwari

  • National Stock Exchange (NSEIN IN) updated rule on Collateral for Margin Requirement in Intraday & F&) Trading. 
  • NSE almost trimmed 1000 Securities acceptable as collateral, leaving only about 730 counters for F&O and intraday traders to pledge for margin trading facility.
  • New Rules will be applicable step by step till Nov-24.

Ohayo Japan | Trump Trade

By Mark Chadwick

  • US stocks gained Monday as an attempted assassination on Donald Trump boosted his election chances
  • Global smartphone shipments rose 6.5% year-over-year in Q2 2024, marking the fourth consecutive quarter of growth
  • Sony aims to transform its gaming IPs into high-quality TV and cinema content, leveraging its skilled personnel and technology

Biopharma Week in Review – July 15, 2024

By Water Tower Research

  • We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A.
  • Morphic Holding, Inc. (MORF) agreed to be acquired by Eli Lilly and Co. (LLY) for $3.2 billion or $57/share in cash, with value primarily driven by lead drug MORF-057, an oral α4β7 integrin inhibitor, in Phase 2s for inflammatory bowel disease (IBD). MORF-057 looks to compete against injectable biologics in the large UC and Crohn’s markets, aiming for similar efficacy, better safety, and oral convenience.
  • Morphic’s novel drug shares the same target as Takeda’s Entyvio, a successful anti-α4β7 antibody. MORF was up 75% last Monday.

Furniture/Furnishings Weekly – July 15, 2024

By Water Tower Research

  • Furniture and furnishings stocks were nicely higher in the week, as the market rotated from larger, growth-oriented, and AI-driven stocks to smaller-cap, value-oriented issues.
  • The WTR Commercial/Contract Furniture Index (+4.4%), Residential Manufacturers & Suppliers Index (+8.3%), and Home Goods Retailers Index (+8.1%) all had strong showings, reflecting the gains seen in the broader Russell 2000 (+5.4%).
  • The Mass Retailers Index fell (-0.4%), in line with the broader moves away from large-cap, technology-oriented stocks. 

The Highlights – Cannabis News for the Week Ending July 12, 2024

By Water Tower Research

  • It was a good week for cannabis stocks, with the US cannabis MSOS ETF gaining 6.15% and global YOLO increasing 5.15%.
  • The Cannabist (NEO: CBST, OTCQX: CBSTF) +16.67% was the biggest winner among the larger MSOs, while MariMed (CSE: MRMD, OTCQX: MRMD) -10.53% lost the most.
  • Politics continue to drive prices and cannabis investors are showing that they prefer a democratic ticket headlined by Vice President Harris rather than President Biden.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Honda Motor Placement – Past Large Deals Analysis – Could Do with a Bit More Correction and more

By | Daily Briefs, ECM

In today’s briefing:

  • Honda Motor Placement – Past Large Deals Analysis – Could Do with a Bit More Correction
  • Remember DiDi Global? We Check in on China’s Dominant Rideshare Company and Review Recent Results
  • Sagility India Pre-IPO Tearsheet


Honda Motor Placement – Past Large Deals Analysis – Could Do with a Bit More Correction

By Sumeet Singh

  • A group of shareholders aims to raise up to US$3.2bn via selling around 5% of Honda Motor (7267 JP).
  • The possibility of such a selldown was flagged by Reuters prior to the deal launch.
  • In our earlier note, we spoke about the deal dynamics. In this note, we talk about the updates since then.

Remember DiDi Global? We Check in on China’s Dominant Rideshare Company and Review Recent Results

By Daniel Hellberg

  • First, we offer a recent history of Didi going back to its June 2021 IPO 
  • Next, we review the company’s annual results from 2020-23 plus Q124
  • Finally, we try to answer the question, “Does Didi need to raise cash soon?”

Sagility India Pre-IPO Tearsheet

By Ethan Aw

  • Sagility India (2058883D IN) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by ICICI Securities, IIFL Securities, Jefferies and JP Morgan. 
  • Sagility India is a pure-play healthcare focused solutions and services provider to Payers (U.S. health insurance companies), and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies). 
  • It supports the core business operations of both Payer and Provider clients. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Morning Views Asia: Adani Ports & Special Economic Zone and more

By | Credit, Daily Briefs

In today’s briefing:

  • Morning Views Asia: Adani Ports & Special Economic Zone, Vedanta Resources


Morning Views Asia: Adani Ports & Special Economic Zone, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Asics (7936 JP): Huge Forecast Revision to Offset Limited Passive Buying and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Asics (7936 JP): Huge Forecast Revision to Offset Limited Passive Buying
  • China Traditional Chinese Medicine (570 HK): Update Provides Fodder for Bulls and Bears
  • Japan – Yet Another Big Round of Passive Selling Expected in August
  • Recently Observed Market Flow Movements Related to Korea’s Value-Up Initiatives
  • Legend Biotech (LEGN US): Takeover Interest – Possible but Tough to Pull Off
  • SK Innovation and SK E&S to Discuss a Potential Merger on 17 July
  • NatWest (NWG): Passive Push from UK Government
  • Quiddity Leaderboard SSE50/180 Dec 24: US$1.6bn+ One-Way; Some Changes to Expectations.
  • HK CEO & Director Dealings (15th Jul 2024): Zhongsheng, Jardine Matheson, FIT Hon Teng, Hon Hai
  • CSI500 Index Rebalance Preview: 50 Changes; 11% Turnover; US$3.4bn Round-Trip Trade


Asics (7936 JP): Huge Forecast Revision to Offset Limited Passive Buying

By Brian Freitas

  • 15 shareholders are looking to sell between 73.9-85m shares (US$1.2bn-US$1.38bn) of ASICS Corp (7936 JP) in a secondary offering that will likely be priced on 23 July.
  • ASICS Corp (7936 JP) has also announced a huge upward revision to its sales and profit forecasts with EPS expected to increase 61% from earlier estimates.
  • Passive buying will be extremely limited in the short-term with the downward pressure offset to a large extent by the sales and earnings revisions.

China Traditional Chinese Medicine (570 HK): Update Provides Fodder for Bulls and Bears

By Arun George

  • China Traditional Chinese Medicine (570 HK)’s monthly update provides ammunition to both the bulls and bears. Since falling on no news on 26 June, the spread has widened to 31.8%. 
  • The bull view is that while the timelines are delayed, the privatisation remains on track as the update shows ongoing progress in satisfying the pre-condition. 
  • The bear view is that progress remains glacial, as the consortium wants to withdraw from a binding offer by failing to satisfy the pre-condition before the long stop date.

Japan – Yet Another Big Round of Passive Selling Expected in August

By Brian Freitas

  • There are a bunch of stocks that have underperformed the Nikkei 225 (NKY INDEX) and their peers and could be deleted from global passive portfolios in August.
  • The deletion from passive portfolios will lead to a liquidity event at the end of August where passive trackers will need to sell multiple days of ADV.
  • Shorts have been built up on all the stocks over the last few months and the extent of the positioning varies across stocks.

Recently Observed Market Flow Movements Related to Korea’s Value-Up Initiatives

By Sanghyun Park

  • Nine companies disclosed value-up plans, with four official and five pending disclosures. Initially, these announcements boosted stock prices, but long-term correlations were inconclusive. Yet, shareholder returns notably rose in H1.
  • NPS increased stakes in three of the nine recently announced value-up companies. They share traits in value-up trading (large caps & low PBR), potentially guiding our strategy as NPS enters.
  • BlackRock’s Hong Kong branch has recently engaged with six Korean asset management firms for potential entrustment of its Asian fund’s Korean investment portion, focusing on the value-up policy.

Legend Biotech (LEGN US): Takeover Interest – Possible but Tough to Pull Off

By Arun George

  • Legend Biotech Corp (LEGN US) shares increased 12% on Friday as a Street Insider report claimed it received takeover interest and hired Centerview Partners to help review the offer.
  • Genscript Biotech (1548 HK), the largest shareholder, shares rose 25%. Genscript responsded that it is not aware of any reasons for these share price movements and any inside information.
  • The chances for an offer are low as the offeror would face several hurdles. Nevertheless, without an offer, the upcoming CARVYKTI commercial production in 2H24 will support the share price.   

SK Innovation and SK E&S to Discuss a Potential Merger on 17 July

By Douglas Kim

  • SK Innovation (096770 KS) and SK E&S plan to hold a board meeting on 17 July to discuss the potential merger between the two companies.
  • If this merger is successful, it would create the eighth largest company in Korea with a combined assets of 106 trillion won (US$77 billion). 
  • Although the merger ratio is not yet available, we believe that this potential merger could potentially benefit SK E&S and SK Inc but could be negative on SK Innovation.

NatWest (NWG): Passive Push from UK Government

By Dimitris Ioannidis

  • The UK government has more than halved its stake in NatWest Group (NWG LN) over the last two years reflecting an improving financial health for the lender.
  • The UK government is a strategic shareholder and the selling is forecasted to cause a passive fund demand in the next two months across four indices.
  • At close of 20 September 2024, the aggregate passive fund demand for NatWest Group (NWG LN) is currently estimated at 22.8m shares, $95.7m and 0.73 days of volume.

Quiddity Leaderboard SSE50/180 Dec 24: US$1.6bn+ One-Way; Some Changes to Expectations.

By Janaghan Jeyakumar, CFA

  • SSE 50 and SSE 180, respectively, aim to represent the performance of the 50 and 180 largest and most liquid A-share stocks listed on the Shanghai Stock Exchange.
  • In this insight, we take a look at the names leading the race to become ADDs and DELs during the December 2024 index rebal event.
  • There have been some changes to the SSE 180 expected ADDs/DELs lists since our last insight.

HK CEO & Director Dealings (15th Jul 2024): Zhongsheng, Jardine Matheson, FIT Hon Teng, Hon Hai

By David Blennerhassett


CSI500 Index Rebalance Preview: 50 Changes; 11% Turnover; US$3.4bn Round-Trip Trade

By Brian Freitas

  • With 70% of the review period now complete, we forecast 50 changes (the maximum permitted) for the CSI Smallcap 500 Index at the close on 13 December.
  • We estimate a one-way turnover of 11.3% at the rebalance resulting in a one-way trade of CNY12.08bn (US$1.7bn). The Information Technology and HealthCare sectors gain at the expense of Industrials.
  • The potential adds have outperformed the potential deletes and the CSI Smallcap 500 Index (SH000905 INDEX) since the start of the year with the outperformance gradually picking up.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Crypto: Crypto Crisp: No Fear and more

By | Crypto, Daily Briefs

In today’s briefing:

  • Crypto Crisp: No Fear, Prices Soar


Crypto Crisp: No Fear, Prices Soar

By Mads Eberhardt

  • The crypto market has recently diverged not only from the rapidly improving liquidity conditions in the broader economy but also from various positive crypto-specific factors such as declining exchange balances, regulatory clarity, reduced Bitcoin miners’ reserves, the historically positive post-Halving period, and the imminent launch of Ethereum spot ETFs.
  • This decoupling has been driven by the German government selling nearly 50,000 bitcoins over the past few weeks, most of which were sold last week, along with the start of repayments to Mt. Gox creditors.
  • The substantial rebound in crypto assets this weekend, as the German Bitcoin selling ended on Friday, highlights that the tumbling prices in recent weeks were merely due to the German government, Mt. Gox, and, not least, the unjustified fear of substantial selling pressure, as we argued in last week’s Crypto Crisp titled ‘Buy the Dip’.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars